3-Bromofuran

3-Bromofuran
Names
IUPAC name
3-Bromofuran
Other names
3-Furyl bromide; beta-Bromofuran
Identifiers
22037-28-1 N
ChemSpider 80460 YesY
Jmol interactive 3D Image
PubChem 89164
Properties
C4H3BrO
Molar mass 146.97 g·mol−1
Density 1.6606 @20 °C
Boiling point 102.5 to 102.6 °C (216.5 to 216.7 °F; 375.6 to 375.8 K)
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
N verify (what is YesYN ?)
Infobox references

3-Bromofuran is a liquid having a boiling point similar to that of water (102.5-102.6 °C), but with density significantly higher (1.6606 g/cm3 at 20 °C) [1]

Synthesis

3-Bromofuran was obtained in minor amounts in 1887 as a byproduct in a reaction of 3-bromofuroic acid with calcium hydroxide.[2] About four decades later this compound was prepared deliberately and in higher yield.[1] Recently, 3-bromofuran has been prepared from 3,4-dibromofuran via ortho-metallation with butyl lithium in good yield.[3] An elegant synthesis of 3-bromofuran is due to Fechtel[4] who prepared this compound via a Diels Alder-bromination-reverse Diels Alder sequence.

Applications

3-Bromofuran is a versatile chemical intermediate, in that it is a convenient starting material for 3-substituted furans, and as such, has found application in the syntheses of drug substances or candidate drugs in a number of therapeutic classes, including chemotherapy agents,[5] HIV drugs,[6] type 2 diabetes,[7] osteoporosis[8] and Alzheimer's disease.[9] Thus, the total synthesis of (+)-cacospongionolide B, a sesterterpene with anti-inflammatory properties,[10] has been accomplished employing 3-furylboronic acid derived from 3-bromofuran.[11] 3-Bromofuran has also found application in the fragrance chemical arena. Thus, 3-bromofuran was reacted with 3,3-dimethylallyl bromide and lithium diisopropylamide in THF solution, followed by reaction at with methyl iodide and N-butyllithium in THF, yielding rosefuran, a constituent chemical of the odor of the rose, and an insect sex attractant.[12] The total synthesis of (−)-neothiobinupharidine, a bioactive alkaloid isolated from Nuphar pumila (the small yellow pond-lily) was accomplished in eight steps employing two moles of 3-bromofuran.[13] Similarly, Salvinorin A, the primary hallucinogenic diterpene compound in Salvia divinorum, a Mexican plant used by Mazatec shamans has been synthesized from 3-bromofuran in eleven steps.[14]

References

  1. 1 2 A. F. Shepard; Winslow, N. R.; Johnson, John R. (1930). "The simple halogen derivatives of furan". J. Am. Chem. Soc. 52 (9): 2083–2090. doi:10.1021/ja01368a057.
  2. ↑ Conzoneri; Oliveri (1887). Gazz. Chim. Ital. 17: 43.
  3. ↑ Carlos Alvarez-Ibarra; Quiroga, Maria L.; Toledano, Emilio (1996). "Synthesis of polysubstituted 3-thiofurans by regiospecific mono-ipso-substitution and ortho-metallation from 3,4-dibromofuran.". Tetrahedron 52 (11): 4065–4078. doi:10.1016/s0040-4020(96)00069-5.
  4. ↑ Guenter Fechtel, "Preparation of furan and cyclopentadiene derivatives as biocides and drug intermediates" East Ger. Patent 246,107 (1987)
  5. ↑ Han-Zhong Zhang; Kasibhatla, Shailaja; Kuemmerle, Jared (2005). "Discovery and Structure-Activity Relationship of 3-Aryl-5-aryl-1,2,4-oxadiazoles as a New Series of Apoptosis Inducers and Potential Anticancer Agents.". Journal of Medicinal Chemistry 48 (16): 5215–5223. doi:10.1021/jm050292k.
  6. ↑ Susan E. Hagen; Domagla, John; Gajda, Christopher (2001). "4-Hydroxy-5,6-dihydropyrones as inhibitors of HIV protease: the effect of heterocyclic substituents at C-6 on antiviral potency and pharmacokinetic parameters". Journal of Medicinal Chemistry 44 (14): 2319–2332. doi:10.1021/jm0003844.
  7. ↑ Qun Dang; Brown, Brian S.; Liu, Yan (2009). "Fructose-1,6-bisphosphatase Inhibitors. 1. Purine Phosphonic Acids as Novel AMP Mimics". Journal of Medicinal Chemistry 52 (14): 2880–2898. doi:10.1021/jm900078f.
  8. ↑ Zhi-Cai Shi, et al., " Preparation of 4-[6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidin-4-yl]-(S)-phenylalanine derivative tryptophan hydroxylase inhibitors for treating osteoporosis ", US PCT Int. Appl. (2010), WO 2010065333 A1 20100610.
  9. ↑ Zhi-Cai Shi, et al., " Preparation of a (((1,2,4-oxadiazolyl)phenyl)morpholino)pyrimidin-4-one compound as a therapeutic tau protein kinase inhibitor ", PCT Int. Appl. (2009), WO 2009035162 A1 20090319.
  10. ↑ Inmaculada Posadas; De Rosa, Salvatore; Terencio, M Carmen (2003). "Cacospongionolide B suppresses the expression of inflammatory enzymes and tumour necrosis factor-α by inhibiting nuclear factor-κB activation". Br J Pharmacol. 138 (8): 1571–1579. doi:10.1038/sj.bjp.0705189.
  11. ↑ Motoko Oshida; Ono, Misaki; Nakazaki, Atsuo (2010). "Total synthesis of (+)-cacospongionolide B". Heterocycles 80 (1): 313–328. doi:10.3987/com-09-s(s)17.
  12. ↑ Peter Weyerstahl; Schenk, Anja; Marschall, Helga (1995). "Structure-odor correlation. Part XXI. Olfactory properties and convenient synthesis of furans and thiophenes related to rosefuran and perillene and their isomers". Liebigs Annalen 6 (10): 1849–1853. doi:10.1002/jlac.1995199510259.
  13. ↑ Daniel J. Jansen; Shenvi, Ryan A. (2013). "Synthesis of (−)-Neothiobinupharidine". Journal of the American Chemical Society 135 (4): 1209–1212. doi:10.1021/ja310778t.
  14. ↑ Hisahiro Hagiwara; Suka, Yuhki; Nojima, Takashi; Suzuki, Toshio (2005). "Second-generation synthesis of salvinorin A". Tetrahedron 65 (25): 4820–4825. doi:10.1016/j.tet.2009.04.053.
This article is issued from Wikipedia - version of the Sunday, November 01, 2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.